Lack of association between prokineticin 2 gene and Japanese methamphetamine dependence

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 133-136

  Kishi, Taro ^a   Kitajima, Tsuyoshi ^a   Tsunoka, Tomoko ^a   Okumura, Takenori ^a   Kawashima, Kunihiro ^a   Okochi, Tomo ^a   Yamanouchi, Yoshio ^a   Kinoshita, Yoko ^a   Ujike, Hiroshi ^b,c   Inada, Toshiya ^b,d   Yamada, Mitsuhiko ^b,e   Uchimura, Naohisa ^b,f   Sora, Ichiro ^b,g   Iyo, Masaomi ^b,h   Ozaki, Norio ^b,i   Iwata, Nakao ^a,b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Japanese Genetics Initiative for Drug Abuse ^*  (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d SEIWA HOSPITAL   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Linkage disequilibrium; Methamphetamine dependence; Prokineticin 2 gene (PROK2); Tagging SNPs

Indexed keywords

METHAMPHETAMINE; PROKINETICIN 2 RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; PATHOGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

EID: 79953033904     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795016994     Document Type: Article

References (25)

1. Falcon, E., McClung, C.A. A role for the circadian genes in drug addiction. Neuropharmacology, 2009, 56(Suppl 1), 91-96.
2. McClung, C.A. Circadian rhythms, the mesolimbic dopaminergic circuit, and drug addiction. Sci.World J., 2007, 7, 194-202.
3. McClung, C.A., Sidiropoulou, K., Vitaterna, M., Takahashi, J.S., White, F.J., Cooper, D.C., Nestler, E.J. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc. Natl. Acad. Sci. USA, 2005, 102, 9377.
4. Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Inada, T., Harano, M., Komiyama, T., Hori, T., Yamada, M., Iyo, M., Sora, I., Sekine, Y., Ozaki, N., Ujike, H., Iwata, N. Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese population. Ann. N.Y. Acad. Sci., 2008, 1139, 83.
5. Barnard, A.R., Nolan, P.M. When clocks go bad: neurobehavioural consequences of disrupted circadian timing. PLoS Genet., 2008, 4(5), e1000040.
6. Kishi, T., Kitajima, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Okumura, T., Tsunoka, T., Ozaki, N., Iwata, N. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients. Neuromol. Med., 2009, 11, 53.
7. Kishi, T., Kitajima, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Okumura, T., Tsunoka, T., Inada, T., Ozaki, N., Iwata, N. Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. Eur. Arch. Psychiat. Clin. Neurosci., 2009, 259, 293.
8. Iijima, M., Nikaido, T., Akiyama, M., Moriya, T., Shibata, S. Methamphetamine-induced, suprachiasmatic nucleus-independent circadian rhythms of activity and mPer gene expression in the striatum of the mouse. Eur. J. Neurosci., 2002, 16(5), 921-929.
9. Masubuchi, S., Honma, S., Abe, H., Ishizaki, K., Namihira, M., Ikeda, M., Honma, K. Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor activity rhythm in rats. Eur. J. Neurosci., 2000, 12, 4206.
10. Masubuchi, S., Honma, S., Abe, H., Nakamura, W., Honma, K. Circadian activity rhythm in methamphetamine-treated Clock mutant mice. Eur. J. Neurosci., 2001, 14(7), 1177-1180.
11. Kishi, T., Kitajima, T., Tsunoka, T., Okumura, T., Okochi, T., Kawashima, K., Inada, T., Ujike, H., Yamada, M., Uchimura, N., Sora, I., Iyo, M., Ozaki, N., Iwata, N. PROKR2 is associated with methamphetamine dependence in the Japanese population. Prog. Neuro-psychopharmacol. Biol. Psychiatry, 2010, 34, 1033.
12. Cheng, M.Y., Bullock, C.M., Li, C., Lee, A.G., Bermak, J.C., Belluzzi, J., Weaver, D.R., Leslie, F.M., Zhou, Q.Y. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature, 2002, 417, 405.
13. Li, J.D., Hu, W.P., Boehmer, L., Cheng, M.Y., Lee, A.G., Jilek, A., Siegel, J.M., Zhou, Q.Y. Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J. Neurosci., 2006, 26, 11615.
14. Zhou, Q.Y., Cheng, M.Y. Prokineticin 2 and Circadian clock output. FEBS J., 2005, 272(22), 5703-5709.
15. Hu, W.P., Li, J.D., Zhang, C., Boehmer, L., Siegel, J.M., Zhou, Q.Y. Altered circadian and homeostatic sleep regulation in prokineticin 2-deficient mice. Sleep, 2007, 30(3), 247-256.
16. Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Inada, T., Harano, M., Komiyama, T., Hori, T., Yamada, M., Iyo, M., Sora, I., Sekine, Y., Ozaki, N., Ujike, H., Iwata, N. Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamineuse disorder in the Japanese population. Ann. N.Y. Acad. Sci., 2008, 1139, 70.
17. Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Inada, T., Harano, M., Komiyama, T., Hori, T., Yamada, M., Iyo, M., Sora, I., Sekine, Y., Ozaki, N., Ujike, H., Iwata, N. Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population. Ann. N. Y. Acad. Sci., 2008, 1139, 63.
18. Barrett, J.C., Fry, B., Maller, J., Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England). 2005, 21(2), 263-265.
19. Dudbridge, F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol., 2003, 25(2), 115-121.
20. Purcell, S., Cherny, S.S., Sham, P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics (Oxford, England), 2003, 19(1), 149-150.
21. Kishi, T., Kitajima, T., Tsunoka, T., Okumura, T., Ikeda, M., Okochi, T., Kinoshita, Y., Kawashima, K., Yamanouchi, Y., Ozaki, N., Iwata, N. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population. Neuromol. Med., 2009, 11, 114.
22. Mohawk, J. A., Baer, M.L., Menaker, M. The methamphetaminesensitive circadian oscillator does not employ canonical clock genes. Proc. Natl. Acad. Sci. USA, 2009, 106(9), 3519-3524.
23. Chakravarti, A. Population genetics--making sense out of sequence. Nat. Genet., 1999, 21(1 Suppl), 56-60.
24. Kishi, T., Tsunoka, T., Ikeda, M., Kitajima, T., Kawashima, K., Okochi, T., Okumura, T., Yamanouchi, Y., Kinoshita, Y., Ujike, H., Inada, T., Yamada, M., Uchimura, N., Sora, I., Iyo, M., Ozaki, N., Iwata, N. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology, 2010, 58, 452.
25. Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Tsunoka, T., Okumura, T., Inada, T., Ujike, H., Yamada, M., Uchimura, N., Sora, I., Iyo, M., Ozaki, N., Iwata, N. A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis. Prog. Neuro-psychopharmacol. Biol. Psychiatry, 2009, 33, 895.